Q1 2019 Inovio Pharmaceuticals Inc Earnings Call Transcript
Good day, and welcome to the Inovio Pharmaceuticals First Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please note this event is being recorded. I'd now like to turn the conference over to Ben Matone, Director of Investor Relations. Please go ahead, sir.
Thank you, operator. Good afternoon everyone and welcome to the Inovio Pharmaceuticals first quarter 2019 investor conference call.
With me today are, Inovio's President and CEO, Dr. J. Joseph Kim, our Chief Financial Officer, Peter Kies and our Chief Scientific Officer, Dr. Laurent Humeau. Today's call is also being webcast live on our website ir.inovio.com and a replay of today's call will be made available. Following a general business update, we will conduct a question-and-answer segment which will be reserved for equity research analysts.
As a reminder, we will be making certain forward-looking statements that relate to our business, which include our plans to develop our immunotherapy platform in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |